Entries by

4. Euripid Stakeholder Dialogue Platform

6th May 2021 in /by

The 4th Meeting of the Stakeholder Dialogue Platform on Pricing of Medicinal Products will take place on Tuesday, 11 May 2021, 10.00-12.00 am. Here you find the event Link (WebEx): https://neak.webex.com/neak-en/j.php?MTID=m18db35996f517b30a915b7638cfb71c5 You can download the agenda here.

Survey among EURIPID members

6th May 2021 in /by

A recent survey among Euripid members confirmed their interest in sharing not only concrete price information but also information on the application of Managed Entry Agreements for individual products. Currently, 13 countries share information on MEAs for all or selected products. Another priority that was recently confirmed by members is the provision of volume information. […]

Pharmaceutical Strategy for Europe

6th May 2021 in /by

Adopted on 25 November 2020, the Pharmaceutical Strategy for Europe aims at creating a future proof regulatory framework and at supporting industry in promoting research and technologies that actually reach patients in order to fulfil their therapeutic needs while addressing market failures. Read more

WHO Fair Pricing Forum 2021

6th May 2021 in /by

The 3rd Fair Pricing Forum took place online from 13-22 April 2021 and focused again on improving access to medicines and health products through fair pricing, following the inaugural forum held in the Netherlands in 2017 (10–11 May) and the second forum in South Africa in 2019 (11-13 April). WHO invited the Euripid Collaboration to present […]